Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLT Header

<< Previous

Bullboard Posts

Next >>

Comment by TommyNickelson Oct 17, 2024 5:26am

238 Views

Post# 36269382

RE:RE:RE:TLT Header

3 patients could be treated by end of November.

The patients treated in September would hit 90 days in December. 74 patients + 1 who passed away early.

Assuming the data is relayed back to Theralase quickly, could be apart of Break Through Designation.

The last 3 would cross 90 days in spring. This data would get submit to the FDA plus all the other points of data that come in.

By summer, would have 6 months on all all patients. And perhaps sufficient data for an AA approval.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec